Summary

The global Oligonucleotide Process Development and Manufacturing market size is predicted to grow from US$ 1306 million in 2025 to US$ 2138 million in 2031; it is expected to grow at a CAGR of 8.6% from 2025 to 2031.
Oligonucleotides are short-chain nucleic acid molecules with extensive applications in gene therapy, vaccine development, and targeted therapies. Oligonucleotide process development involves the optimization of the entire production workflow, from nucleotide monomer synthesis and solid-phase synthesis to purification and final drug formulation, ensuring high purity, high yield, and scalability. Drug manufacturing must comply with Good Manufacturing Practices (GMP), including stringent quality control, sterile environments, and advanced process scale-up technologies to ensure the safety and efficacy of the final product. With the rapid advancement of nucleic acid therapeutics, efficient, cost-effective, and scalable process development is critical for accelerating new drug commercialization.
United States market for Oligonucleotide Process Development and Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Oligonucleotide Process Development and Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Oligonucleotide Process Development and Manufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Oligonucleotide Process Development and Manufacturing players cover ST Pharm, EUROAPI, Danaher(IDT), Merck, Eurofins Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Oligonucleotide Process Development and Manufacturing Industry Forecast” looks at past sales and reviews total world Oligonucleotide Process Development and Manufacturing sales in 2024, providing a comprehensive analysis by region and market sector of projected Oligonucleotide Process Development and Manufacturing sales for 2025 through 2031. With Oligonucleotide Process Development and Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide Process Development and Manufacturing industry.
This Insight Report provides a comprehensive analysis of the global Oligonucleotide Process Development and Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oligonucleotide Process Development and Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oligonucleotide Process Development and Manufacturing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide Process Development and Manufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide Process Development and Manufacturing.
This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide Process Development and Manufacturing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Oligonucleotide Process Development
Oligonucleotide Manufacturing
Segmentation by Application:
Pharmaceuticals
Scientific Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ST Pharm
EUROAPI
Danaher(IDT)
Merck
Eurofins Scientific
Thermo Fisher Scientific
Agilent Technologies
Nippon Shokubai
Eurogentec
Ajinomoto Bio-Pharma
PeptiStar
Bachem
CordenPharma
Guangzhou RiboBio
Hongene Biotech
WuXi AppTec
Veliter
Ribobay Pharma
ChemExpress
Asymchem

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oligonucleotide Process Development and Manufacturing Market Size (2020-2031)
2.1.2 Oligonucleotide Process Development and Manufacturing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Oligonucleotide Process Development and Manufacturing by Country/Region (2020, 2024 & 2031)
2.2 Oligonucleotide Process Development and Manufacturing Segment by Type
2.2.1 Oligonucleotide Process Development
2.2.2 Oligonucleotide Manufacturing
2.3 Oligonucleotide Process Development and Manufacturing Market Size by Type
2.3.1 Oligonucleotide Process Development and Manufacturing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Oligonucleotide Process Development and Manufacturing Market Size Market Share by Type (2020-2025)
2.4 Oligonucleotide Process Development and Manufacturing Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Scientific Research
2.5 Oligonucleotide Process Development and Manufacturing Market Size by Application
2.5.1 Oligonucleotide Process Development and Manufacturing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Oligonucleotide Process Development and Manufacturing Market Size Market Share by Application (2020-2025)
3 Oligonucleotide Process Development and Manufacturing Market Size by Player
3.1 Oligonucleotide Process Development and Manufacturing Market Size Market Share by Player
3.1.1 Global Oligonucleotide Process Development and Manufacturing Revenue by Player (2020-2025)
3.1.2 Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Player (2020-2025)
3.2 Global Oligonucleotide Process Development and Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Oligonucleotide Process Development and Manufacturing by Region
4.1 Oligonucleotide Process Development and Manufacturing Market Size by Region (2020-2025)
4.2 Global Oligonucleotide Process Development and Manufacturing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oligonucleotide Process Development and Manufacturing Market Size Growth (2020-2025)
4.4 APAC Oligonucleotide Process Development and Manufacturing Market Size Growth (2020-2025)
4.5 Europe Oligonucleotide Process Development and Manufacturing Market Size Growth (2020-2025)
4.6 Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size Growth (2020-2025)
5 Americas
5.1 Americas Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025)
5.2 Americas Oligonucleotide Process Development and Manufacturing Market Size by Type (2020-2025)
5.3 Americas Oligonucleotide Process Development and Manufacturing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oligonucleotide Process Development and Manufacturing Market Size by Region (2020-2025)
6.2 APAC Oligonucleotide Process Development and Manufacturing Market Size by Type (2020-2025)
6.3 APAC Oligonucleotide Process Development and Manufacturing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025)
7.2 Europe Oligonucleotide Process Development and Manufacturing Market Size by Type (2020-2025)
7.3 Europe Oligonucleotide Process Development and Manufacturing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oligonucleotide Process Development and Manufacturing by Region (2020-2025)
8.2 Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size by Type (2020-2025)
8.3 Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Oligonucleotide Process Development and Manufacturing Market Forecast
10.1 Global Oligonucleotide Process Development and Manufacturing Forecast by Region (2026-2031)
10.1.1 Global Oligonucleotide Process Development and Manufacturing Forecast by Region (2026-2031)
10.1.2 Americas Oligonucleotide Process Development and Manufacturing Forecast
10.1.3 APAC Oligonucleotide Process Development and Manufacturing Forecast
10.1.4 Europe Oligonucleotide Process Development and Manufacturing Forecast
10.1.5 Middle East & Africa Oligonucleotide Process Development and Manufacturing Forecast
10.2 Americas Oligonucleotide Process Development and Manufacturing Forecast by Country (2026-2031)
10.2.1 United States Market Oligonucleotide Process Development and Manufacturing Forecast
10.2.2 Canada Market Oligonucleotide Process Development and Manufacturing Forecast
10.2.3 Mexico Market Oligonucleotide Process Development and Manufacturing Forecast
10.2.4 Brazil Market Oligonucleotide Process Development and Manufacturing Forecast
10.3 APAC Oligonucleotide Process Development and Manufacturing Forecast by Region (2026-2031)
10.3.1 China Oligonucleotide Process Development and Manufacturing Market Forecast
10.3.2 Japan Market Oligonucleotide Process Development and Manufacturing Forecast
10.3.3 Korea Market Oligonucleotide Process Development and Manufacturing Forecast
10.3.4 Southeast Asia Market Oligonucleotide Process Development and Manufacturing Forecast
10.3.5 India Market Oligonucleotide Process Development and Manufacturing Forecast
10.3.6 Australia Market Oligonucleotide Process Development and Manufacturing Forecast
10.4 Europe Oligonucleotide Process Development and Manufacturing Forecast by Country (2026-2031)
10.4.1 Germany Market Oligonucleotide Process Development and Manufacturing Forecast
10.4.2 France Market Oligonucleotide Process Development and Manufacturing Forecast
10.4.3 UK Market Oligonucleotide Process Development and Manufacturing Forecast
10.4.4 Italy Market Oligonucleotide Process Development and Manufacturing Forecast
10.4.5 Russia Market Oligonucleotide Process Development and Manufacturing Forecast
10.5 Middle East & Africa Oligonucleotide Process Development and Manufacturing Forecast by Region (2026-2031)
10.5.1 Egypt Market Oligonucleotide Process Development and Manufacturing Forecast
10.5.2 South Africa Market Oligonucleotide Process Development and Manufacturing Forecast
10.5.3 Israel Market Oligonucleotide Process Development and Manufacturing Forecast
10.5.4 Turkey Market Oligonucleotide Process Development and Manufacturing Forecast
10.6 Global Oligonucleotide Process Development and Manufacturing Forecast by Type (2026-2031)
10.7 Global Oligonucleotide Process Development and Manufacturing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Oligonucleotide Process Development and Manufacturing Forecast
11 Key Players Analysis
11.1 ST Pharm
11.1.1 ST Pharm Company Information
11.1.2 ST Pharm Oligonucleotide Process Development and Manufacturing Product Offered
11.1.3 ST Pharm Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 ST Pharm Main Business Overview
11.1.5 ST Pharm Latest Developments
11.2 EUROAPI
11.2.1 EUROAPI Company Information
11.2.2 EUROAPI Oligonucleotide Process Development and Manufacturing Product Offered
11.2.3 EUROAPI Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 EUROAPI Main Business Overview
11.2.5 EUROAPI Latest Developments
11.3 Danaher(IDT)
11.3.1 Danaher(IDT) Company Information
11.3.2 Danaher(IDT) Oligonucleotide Process Development and Manufacturing Product Offered
11.3.3 Danaher(IDT) Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Danaher(IDT) Main Business Overview
11.3.5 Danaher(IDT) Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Oligonucleotide Process Development and Manufacturing Product Offered
11.4.3 Merck Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Information
11.5.2 Eurofins Scientific Oligonucleotide Process Development and Manufacturing Product Offered
11.5.3 Eurofins Scientific Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Eurofins Scientific Main Business Overview
11.5.5 Eurofins Scientific Latest Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Information
11.6.2 Thermo Fisher Scientific Oligonucleotide Process Development and Manufacturing Product Offered
11.6.3 Thermo Fisher Scientific Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Thermo Fisher Scientific Main Business Overview
11.6.5 Thermo Fisher Scientific Latest Developments
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Information
11.7.2 Agilent Technologies Oligonucleotide Process Development and Manufacturing Product Offered
11.7.3 Agilent Technologies Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Agilent Technologies Main Business Overview
11.7.5 Agilent Technologies Latest Developments
11.8 Nippon Shokubai
11.8.1 Nippon Shokubai Company Information
11.8.2 Nippon Shokubai Oligonucleotide Process Development and Manufacturing Product Offered
11.8.3 Nippon Shokubai Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Nippon Shokubai Main Business Overview
11.8.5 Nippon Shokubai Latest Developments
11.9 Eurogentec
11.9.1 Eurogentec Company Information
11.9.2 Eurogentec Oligonucleotide Process Development and Manufacturing Product Offered
11.9.3 Eurogentec Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Eurogentec Main Business Overview
11.9.5 Eurogentec Latest Developments
11.10 Ajinomoto Bio-Pharma
11.10.1 Ajinomoto Bio-Pharma Company Information
11.10.2 Ajinomoto Bio-Pharma Oligonucleotide Process Development and Manufacturing Product Offered
11.10.3 Ajinomoto Bio-Pharma Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Ajinomoto Bio-Pharma Main Business Overview
11.10.5 Ajinomoto Bio-Pharma Latest Developments
11.11 PeptiStar
11.11.1 PeptiStar Company Information
11.11.2 PeptiStar Oligonucleotide Process Development and Manufacturing Product Offered
11.11.3 PeptiStar Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 PeptiStar Main Business Overview
11.11.5 PeptiStar Latest Developments
11.12 Bachem
11.12.1 Bachem Company Information
11.12.2 Bachem Oligonucleotide Process Development and Manufacturing Product Offered
11.12.3 Bachem Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Bachem Main Business Overview
11.12.5 Bachem Latest Developments
11.13 CordenPharma
11.13.1 CordenPharma Company Information
11.13.2 CordenPharma Oligonucleotide Process Development and Manufacturing Product Offered
11.13.3 CordenPharma Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 CordenPharma Main Business Overview
11.13.5 CordenPharma Latest Developments
11.14 Guangzhou RiboBio
11.14.1 Guangzhou RiboBio Company Information
11.14.2 Guangzhou RiboBio Oligonucleotide Process Development and Manufacturing Product Offered
11.14.3 Guangzhou RiboBio Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Guangzhou RiboBio Main Business Overview
11.14.5 Guangzhou RiboBio Latest Developments
11.15 Hongene Biotech
11.15.1 Hongene Biotech Company Information
11.15.2 Hongene Biotech Oligonucleotide Process Development and Manufacturing Product Offered
11.15.3 Hongene Biotech Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Hongene Biotech Main Business Overview
11.15.5 Hongene Biotech Latest Developments
11.16 WuXi AppTec
11.16.1 WuXi AppTec Company Information
11.16.2 WuXi AppTec Oligonucleotide Process Development and Manufacturing Product Offered
11.16.3 WuXi AppTec Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 WuXi AppTec Main Business Overview
11.16.5 WuXi AppTec Latest Developments
11.17 Veliter
11.17.1 Veliter Company Information
11.17.2 Veliter Oligonucleotide Process Development and Manufacturing Product Offered
11.17.3 Veliter Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Veliter Main Business Overview
11.17.5 Veliter Latest Developments
11.18 Ribobay Pharma
11.18.1 Ribobay Pharma Company Information
11.18.2 Ribobay Pharma Oligonucleotide Process Development and Manufacturing Product Offered
11.18.3 Ribobay Pharma Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Ribobay Pharma Main Business Overview
11.18.5 Ribobay Pharma Latest Developments
11.19 ChemExpress
11.19.1 ChemExpress Company Information
11.19.2 ChemExpress Oligonucleotide Process Development and Manufacturing Product Offered
11.19.3 ChemExpress Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 ChemExpress Main Business Overview
11.19.5 ChemExpress Latest Developments
11.20 Asymchem
11.20.1 Asymchem Company Information
11.20.2 Asymchem Oligonucleotide Process Development and Manufacturing Product Offered
11.20.3 Asymchem Oligonucleotide Process Development and Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Asymchem Main Business Overview
11.20.5 Asymchem Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Oligonucleotide Process Development and Manufacturing Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Oligonucleotide Process Development and Manufacturing Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oligonucleotide Process Development
Table 4. Major Players of Oligonucleotide Manufacturing
Table 5. Oligonucleotide Process Development and Manufacturing Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Oligonucleotide Process Development and Manufacturing Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Oligonucleotide Process Development and Manufacturing Market Size Market Share by Type (2020-2025)
Table 8. Oligonucleotide Process Development and Manufacturing Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Oligonucleotide Process Development and Manufacturing Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Oligonucleotide Process Development and Manufacturing Market Size Market Share by Application (2020-2025)
Table 11. Global Oligonucleotide Process Development and Manufacturing Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Player (2020-2025)
Table 13. Oligonucleotide Process Development and Manufacturing Key Players Head office and Products Offered
Table 14. Oligonucleotide Process Development and Manufacturing Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Oligonucleotide Process Development and Manufacturing Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Oligonucleotide Process Development and Manufacturing Market Size Market Share by Region (2020-2025)
Table 19. Global Oligonucleotide Process Development and Manufacturing Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Oligonucleotide Process Development and Manufacturing Market Size Market Share by Country (2020-2025)
Table 23. Americas Oligonucleotide Process Development and Manufacturing Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Oligonucleotide Process Development and Manufacturing Market Size Market Share by Type (2020-2025)
Table 25. Americas Oligonucleotide Process Development and Manufacturing Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Oligonucleotide Process Development and Manufacturing Market Size Market Share by Application (2020-2025)
Table 27. APAC Oligonucleotide Process Development and Manufacturing Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Oligonucleotide Process Development and Manufacturing Market Size Market Share by Region (2020-2025)
Table 29. APAC Oligonucleotide Process Development and Manufacturing Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Oligonucleotide Process Development and Manufacturing Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Oligonucleotide Process Development and Manufacturing Market Size Market Share by Country (2020-2025)
Table 33. Europe Oligonucleotide Process Development and Manufacturing Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Oligonucleotide Process Development and Manufacturing Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Oligonucleotide Process Development and Manufacturing
Table 39. Key Market Challenges & Risks of Oligonucleotide Process Development and Manufacturing
Table 40. Key Industry Trends of Oligonucleotide Process Development and Manufacturing
Table 41. Global Oligonucleotide Process Development and Manufacturing Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Oligonucleotide Process Development and Manufacturing Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Oligonucleotide Process Development and Manufacturing Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Oligonucleotide Process Development and Manufacturing Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. ST Pharm Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 46. ST Pharm Oligonucleotide Process Development and Manufacturing Product Offered
Table 47. ST Pharm Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. ST Pharm Main Business
Table 49. ST Pharm Latest Developments
Table 50. EUROAPI Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 51. EUROAPI Oligonucleotide Process Development and Manufacturing Product Offered
Table 52. EUROAPI Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. EUROAPI Main Business
Table 54. EUROAPI Latest Developments
Table 55. Danaher(IDT) Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 56. Danaher(IDT) Oligonucleotide Process Development and Manufacturing Product Offered
Table 57. Danaher(IDT) Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Danaher(IDT) Main Business
Table 59. Danaher(IDT) Latest Developments
Table 60. Merck Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 61. Merck Oligonucleotide Process Development and Manufacturing Product Offered
Table 62. Merck Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Merck Main Business
Table 64. Merck Latest Developments
Table 65. Eurofins Scientific Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 66. Eurofins Scientific Oligonucleotide Process Development and Manufacturing Product Offered
Table 67. Eurofins Scientific Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Eurofins Scientific Main Business
Table 69. Eurofins Scientific Latest Developments
Table 70. Thermo Fisher Scientific Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 71. Thermo Fisher Scientific Oligonucleotide Process Development and Manufacturing Product Offered
Table 72. Thermo Fisher Scientific Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Thermo Fisher Scientific Main Business
Table 74. Thermo Fisher Scientific Latest Developments
Table 75. Agilent Technologies Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 76. Agilent Technologies Oligonucleotide Process Development and Manufacturing Product Offered
Table 77. Agilent Technologies Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Agilent Technologies Main Business
Table 79. Agilent Technologies Latest Developments
Table 80. Nippon Shokubai Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 81. Nippon Shokubai Oligonucleotide Process Development and Manufacturing Product Offered
Table 82. Nippon Shokubai Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Nippon Shokubai Main Business
Table 84. Nippon Shokubai Latest Developments
Table 85. Eurogentec Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 86. Eurogentec Oligonucleotide Process Development and Manufacturing Product Offered
Table 87. Eurogentec Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Eurogentec Main Business
Table 89. Eurogentec Latest Developments
Table 90. Ajinomoto Bio-Pharma Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 91. Ajinomoto Bio-Pharma Oligonucleotide Process Development and Manufacturing Product Offered
Table 92. Ajinomoto Bio-Pharma Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Ajinomoto Bio-Pharma Main Business
Table 94. Ajinomoto Bio-Pharma Latest Developments
Table 95. PeptiStar Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 96. PeptiStar Oligonucleotide Process Development and Manufacturing Product Offered
Table 97. PeptiStar Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. PeptiStar Main Business
Table 99. PeptiStar Latest Developments
Table 100. Bachem Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 101. Bachem Oligonucleotide Process Development and Manufacturing Product Offered
Table 102. Bachem Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Bachem Main Business
Table 104. Bachem Latest Developments
Table 105. CordenPharma Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 106. CordenPharma Oligonucleotide Process Development and Manufacturing Product Offered
Table 107. CordenPharma Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. CordenPharma Main Business
Table 109. CordenPharma Latest Developments
Table 110. Guangzhou RiboBio Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 111. Guangzhou RiboBio Oligonucleotide Process Development and Manufacturing Product Offered
Table 112. Guangzhou RiboBio Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Guangzhou RiboBio Main Business
Table 114. Guangzhou RiboBio Latest Developments
Table 115. Hongene Biotech Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 116. Hongene Biotech Oligonucleotide Process Development and Manufacturing Product Offered
Table 117. Hongene Biotech Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Hongene Biotech Main Business
Table 119. Hongene Biotech Latest Developments
Table 120. WuXi AppTec Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 121. WuXi AppTec Oligonucleotide Process Development and Manufacturing Product Offered
Table 122. WuXi AppTec Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. WuXi AppTec Main Business
Table 124. WuXi AppTec Latest Developments
Table 125. Veliter Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 126. Veliter Oligonucleotide Process Development and Manufacturing Product Offered
Table 127. Veliter Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Veliter Main Business
Table 129. Veliter Latest Developments
Table 130. Ribobay Pharma Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 131. Ribobay Pharma Oligonucleotide Process Development and Manufacturing Product Offered
Table 132. Ribobay Pharma Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Ribobay Pharma Main Business
Table 134. Ribobay Pharma Latest Developments
Table 135. ChemExpress Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 136. ChemExpress Oligonucleotide Process Development and Manufacturing Product Offered
Table 137. ChemExpress Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. ChemExpress Main Business
Table 139. ChemExpress Latest Developments
Table 140. Asymchem Details, Company Type, Oligonucleotide Process Development and Manufacturing Area Served and Its Competitors
Table 141. Asymchem Oligonucleotide Process Development and Manufacturing Product Offered
Table 142. Asymchem Oligonucleotide Process Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. Asymchem Main Business
Table 144. Asymchem Latest Developments


List of Figures
Figure 1. Oligonucleotide Process Development and Manufacturing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oligonucleotide Process Development and Manufacturing Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Oligonucleotide Process Development and Manufacturing Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Oligonucleotide Process Development and Manufacturing Sales Market Share by Country/Region (2024)
Figure 8. Oligonucleotide Process Development and Manufacturing Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Oligonucleotide Process Development and Manufacturing Market Size Market Share by Type in 2024
Figure 10. Oligonucleotide Process Development and Manufacturing in Pharmaceuticals
Figure 11. Global Oligonucleotide Process Development and Manufacturing Market: Pharmaceuticals (2020-2025) & ($ millions)
Figure 12. Oligonucleotide Process Development and Manufacturing in Scientific Research
Figure 13. Global Oligonucleotide Process Development and Manufacturing Market: Scientific Research (2020-2025) & ($ millions)
Figure 14. Global Oligonucleotide Process Development and Manufacturing Market Size Market Share by Application in 2024
Figure 15. Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Player in 2024
Figure 16. Global Oligonucleotide Process Development and Manufacturing Market Size Market Share by Region (2020-2025)
Figure 17. Americas Oligonucleotide Process Development and Manufacturing Market Size 2020-2025 ($ millions)
Figure 18. APAC Oligonucleotide Process Development and Manufacturing Market Size 2020-2025 ($ millions)
Figure 19. Europe Oligonucleotide Process Development and Manufacturing Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size 2020-2025 ($ millions)
Figure 21. Americas Oligonucleotide Process Development and Manufacturing Value Market Share by Country in 2024
Figure 22. United States Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Oligonucleotide Process Development and Manufacturing Market Size Market Share by Region in 2024
Figure 27. APAC Oligonucleotide Process Development and Manufacturing Market Size Market Share by Type (2020-2025)
Figure 28. APAC Oligonucleotide Process Development and Manufacturing Market Size Market Share by Application (2020-2025)
Figure 29. China Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 33. India Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Oligonucleotide Process Development and Manufacturing Market Size Market Share by Country in 2024
Figure 36. Europe Oligonucleotide Process Development and Manufacturing Market Size Market Share by Type (2020-2025)
Figure 37. Europe Oligonucleotide Process Development and Manufacturing Market Size Market Share by Application (2020-2025)
Figure 38. Germany Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 39. France Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Oligonucleotide Process Development and Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 52. APAC Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 53. Europe Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 55. United States Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 56. Canada Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 57. Mexico Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 58. Brazil Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 59. China Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 60. Japan Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 61. Korea Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 63. India Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 64. Australia Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 65. Germany Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 66. France Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 67. UK Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 68. Italy Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 69. Russia Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 70. Egypt Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 71. South Africa Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 72. Israel Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 73. Turkey Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)
Figure 74. Global Oligonucleotide Process Development and Manufacturing Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Oligonucleotide Process Development and Manufacturing Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Oligonucleotide Process Development and Manufacturing Market Size 2026-2031 ($ millions)